Evidence supporting the use of: Vitamin E (alpha-tocopherol succinate)
For the health condition: Cataracts

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (alpha-tocopherol succinate) has been investigated for its potential role in preventing or slowing the progression of cataracts, primarily due to its antioxidant properties. Oxidative stress is believed to contribute to the development of cataracts by damaging lens proteins and lipids, leading to clouding of the lens. Vitamin E, as a lipid-soluble antioxidant, could theoretically protect the lens from oxidative damage.

Some epidemiological studies have shown a modest association between higher dietary or plasma vitamin E levels and a lower risk of cataract formation. Small interventional studies have also suggested potential benefits, but results are inconsistent and sometimes confounded by the use of multivitamin combinations or co-administration with other antioxidants (such as vitamin C and beta-carotene).

Large randomized controlled trials (RCTs), such as the Age-Related Eye Disease Study (AREDS) and the Physicians’ Health Study II, have not found significant evidence that vitamin E supplementation prevents the development or progression of age-related cataracts. Systematic reviews and meta-analyses generally conclude that the current evidence does not strongly support vitamin E supplementation for cataracts, though a possible small protective effect from diet cannot be ruled out.

In summary, while there is a scientific rationale and some observational data, robust clinical evidence for vitamin E’s efficacy in cataract prevention or treatment is lacking. It is not considered a primary or proven therapy for cataracts.

More about Vitamin E (alpha-tocopherol succinate)
More about Cataracts

Products containing Vitamin E (alpha-tocopherol succinate)

We currently have no products on Vitabase that contain this ingredient.